Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Antineoplaston A10
Cat. No.:
OB0225LY-0072
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Antineoplaston A10 is a potent Ras inhibitor with antitumor effect.
Synonym:
NSC-648539; 91531-30-5; N-[(3S)-2,6-Dioxopiperidin-3-yl]-2-phenylacetamide; Antineoplaston-A10; (S)-N-(2,6-Dioxopiperidin-3-yl)-2-phenylacetamide; N-[(3S)-2,6-Dioxo-3-piperidyl]-2-phenyl-acetamide; Benzeneacetamide, N-(2,6-dioxo-3-piperidinyl)-, (S)-
CAS No.:
91531-30-5
Compound CID:
56260
Formula:
C13H14N2O3
Formula Weight:
246.26
Specification
Relative Density:
1.27 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Antineoplaston A10 regulates the cell cycle and enhances the immune response to inhibit tumor growth.
Library Information
Targets:
GTPase superfamily
Receptors:
Ras
Pathways:
Metabolism; Apoptosis; GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
h4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 40.61 mM
